Aslam M Ansari

7381702, Jun 3, 2008

Jun 15, 2006

11/424295

Nnochiri N. Ekwuribe - Cary NC, US
Christopher H. Price - Chapel Hill NC, US
James Gordon Still - Raleigh NC, US
Jennifer Ann Filbey - Raleigh NC, US
Aslam M. Ansari - Montgomery Village MD, US
Amy L. Odenbaugh - Morrisville NC, US
Balasingam Radhakrishnan - Chapel Hill NC, US

Biocon Limited

A61K 38/28
A61K 38/00
A61K 38/02
C07K 2/00

514 3, 514 2, 530300, 530303

Methods of treating diabetes mellitus in a patient in need of such treatment include administering an effective amount of an insulin drug to the patient in order to treat diabetes mellitus in the patient. Methods according to the present invention may “activate” the liver, potentially restoring normal glucose homeostasis to individuals suffering from diabetes mellitus.

7423014, Sep 9, 2008

Dec 21, 2005

11/314309

Nnochiri N. Ekwuribe - Cary NC, US
Christopher H. Price - Chapel Hill NC, US
James Gordon Still - Raleigh NC, US
Jennifer Ann Filbey - Raleigh NC, US
Aslam M. Ansari - Montgomery Village MD, US
Amy L. Odenbaugh - Morrisville NC, US
Balasingam Radhakrishnan - Chapel Hill NC, US

Biocon Limited

A61K 38/28
A61K 47/48

514 3

Methods of treating diabetes mellitus in a patient in need of such treatment include administering an effective amount of an insulin polypeptide-oligomer conjugate of formula V.

20140100178, Apr 10, 2014

Oct 4, 2012

13/645436

Aslam Ansari - Gaithersburg MD, US
Sanjay Gupta - Woodbridge VA, US

A61K 47/48

514 27, 536 174

A system for selectively delivering drugs to target tissues is provided. The system includes a drug-linker-saccharide-drug conjugate (D-L-A-D1). The linker includes a functional group that is recognized and cleaved by enzyme in the target phases. The recognition segment is preferably a malaria drugs. The carrier is preferably hydrophilic, biodegradable and biocompatible particle. Any drug may be delivered using a conjugate prepared according to the invention.